US Patent 11123406 Rapid-acting insulin compositions
Patent 11123406 was granted and assigned to Eli Lilly and Company on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 14, 2018
Date of Patent
September 21, 2021
Patent Applicant
Patent Application Number
20180514
Patent Citations Received
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11123406 Rapid-acting insulin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
